Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Vascular endothelial growth factor pharmacogenetics: a new perspective for anti-angiogenic therapy.

Pasqualetti G, Danesi R, Del Tacca M, Bocci G.

Pharmacogenomics. 2007 Jan;8(1):49-66. Review.

PMID:
17187509
[PubMed - indexed for MEDLINE]
2.

Vascular endothelial growth factor and anti-angiogenic peptides as therapeutic and investigational molecules.

Zachary I.

IDrugs. 2003 Mar;6(3):224-31. Review.

PMID:
12789611
[PubMed - indexed for MEDLINE]
3.

Angiogenesis and hypertension: the dual role of anti-hypertensive and anti-angiogenic therapies.

Ferroni P, Della-Morte D, Palmirotta R, Rundek T, Guadagni F, Roselli M.

Curr Vasc Pharmacol. 2012 Jul;10(4):479-93. Review.

PMID:
22272903
[PubMed - indexed for MEDLINE]
4.

Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.

Shibuya M.

BMB Rep. 2008 Apr 30;41(4):278-86. Review.

PMID:
18452647
[PubMed - indexed for MEDLINE]
Free Article
5.

The function of vascular endothelial growth factor.

Nieves BJ, D'Amore PA, Bryan BA.

Biofactors. 2009 Jul-Aug;35(4):332-7. doi: 10.1002/biof.46. Review.

PMID:
19415738
[PubMed - indexed for MEDLINE]
6.

Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.

Shibuya M.

FEBS J. 2009 Sep;276(17):4636-43. doi: 10.1111/j.1742-4658.2009.07175.x. Epub 2009 Jul 31. Review.

PMID:
19664071
[PubMed - indexed for MEDLINE]
7.

Establishment of canine hemangiosarcoma xenograft models expressing endothelial growth factors, their receptors, and angiogenesis-associated homeobox genes.

Kodama A, Sakai H, Matsuura S, Murakami M, Murai A, Mori T, Maruo K, Kimura T, Masegi T, Yanai T.

BMC Cancer. 2009 Oct 14;9:363. doi: 10.1186/1471-2407-9-363.

PMID:
19825192
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Antiangiogenic therapies targeting the vascular endothelia growth factor signaling system.

Tie J, Desai J.

Crit Rev Oncog. 2012;17(1):51-67. Review.

PMID:
22471664
[PubMed - indexed for MEDLINE]
9.

Therapeutics targeting angiogenesis: genetics and epigenetics, extracellular miRNAs and signaling networks (Review).

Katoh M.

Int J Mol Med. 2013 Oct;32(4):763-7. doi: 10.3892/ijmm.2013.1444. Epub 2013 Jul 16. Review.

PMID:
23863927
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?

Fischer C, Mazzone M, Jonckx B, Carmeliet P.

Nat Rev Cancer. 2008 Dec;8(12):942-56. doi: 10.1038/nrc2524. Review.

PMID:
19029957
[PubMed - indexed for MEDLINE]
11.

'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.

Kerbel RS, Viloria-Petit A, Klement G, Rak J.

Eur J Cancer. 2000 Jun;36(10):1248-57. Review.

PMID:
10882863
[PubMed - indexed for MEDLINE]
12.

Vascular endothelial growth factor and bevacitumab in breast cancer.

Bando H.

Breast Cancer. 2007;14(2):163-73. Review.

PMID:
17485901
[PubMed - indexed for MEDLINE]
Free Article
13.

Antiangiogenesis, anti-VEGF(R) and outlook.

Petersen I.

Recent Results Cancer Res. 2007;176:189-99. Review.

PMID:
17607926
[PubMed - indexed for MEDLINE]
14.

Genetic predictors of response to photodynamictherapy.

Parmeggiani F, Gemmati D, Costagliola C, Semeraro F, Perri P, D'Angelo S, Romano MR, De Nadai K, Sebastiani A, Incorvaia C.

Mol Diagn Ther. 2011 Aug 1;15(4):195-210. doi: 10.2165/11592270-000000000-00000. Review.

PMID:
21913742
[PubMed - indexed for MEDLINE]
15.

Targeting angiogenesis in head and neck cancer.

Seiwert TY, Cohen EE.

Semin Oncol. 2008 Jun;35(3):274-85. doi: 10.1053/j.seminoncol.2008.03.005. Review.

PMID:
18544442
[PubMed - indexed for MEDLINE]
16.

Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer.

Tugues S, Koch S, Gualandi L, Li X, Claesson-Welsh L.

Mol Aspects Med. 2011 Apr;32(2):88-111. doi: 10.1016/j.mam.2011.04.004. Epub 2011 May 6. Review.

PMID:
21565214
[PubMed - indexed for MEDLINE]
17.

Targeting tumorangiogenesis in lung cancer by suppression of VEGF and its receptor - results from clinical trials and novel experimental approaches.

Kuhn H, Hammerschmidt S, Wirtz H.

Curr Med Chem. 2007;14(30):3157-65. Review.

PMID:
18220749
[PubMed - indexed for MEDLINE]
18.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
[PubMed - indexed for MEDLINE]
19.

Vascular endothelial growth factor and vascular endothelial growth factor receptor inhibitors as anti-angiogenic agents in cancer therapy.

Veeravagu A, Hsu AR, Cai W, Hou LC, Tse VC, Chen X.

Recent Pat Anticancer Drug Discov. 2007 Jan;2(1):59-71. Review.

PMID:
18221053
[PubMed - indexed for MEDLINE]
20.

Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.

Ng EW, Adamis AP.

Can J Ophthalmol. 2005 Jun;40(3):352-68. Review.

PMID:
15947805
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk